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Introduction
Signs & Symptoms

“More than half a million women are diagnosed with cervical cancer and the
disease results in over 300,000 deaths worldwide” (Cohen, Jhingran, Oaknin, &
Denny, 2019, p. 169). Studies have shown that the human papilloma virus (HPV) is
what causes cervical cancer (Johnson, James, Marzan, & Armaos, 2019). “Globally,
70% of invasive cervical cancers are caused by infection with HPV 16 and 18” highrisk subtypes (Kusumlata & Devi, 2019, p. 2). Due to the lack of organized
screening, lower income countries are more at risk of the disease. The rates of
mortality have decreased over the past 30 years in higher-income countries due to
HPV screening programs and vaccines (Cohen et al., 2019). The Papanicolau (Pap)
test is what healthcare providers use to screen for cervical cancer (Akinlotan et al.,
2017). Prophylactic vaccination for HPV is considered the most preventative
against cervical cancer (Kessler, 2017). The two most common forms of cervical
cancer are squamous cell carcinoma and adenocarcinoma (Johnson, et al., 2019).
The stage of prognosis determines what treatment option is used, whether its
surgery, chemotherapy, radiation or a combination of them all. There is an 85% to
90% success rate for early treatment for cervical cancer that’s confined to the
cervix by having surgery to remove the cancer tissue (Kusumlata & Devi, 2019).
Today’s healthcare providers have plenty of opportunities to impact the community
on education and preventative measures for cervical cancer to reduce the number
of incidences (Johnson et al., 2019).

Image 1: Cervix (Mayo Clinic, 2019).

Significance of
Pathophysiology

Underlying
Pathophysiology
The cervix is located on the lower end of the uterus. The “cervix connects the body of
uterus to the vagina (birth canal)” (American Cancer Society, 2016). There are two
types of cervix cells which are glandular cells in the endocervix and squamous cells in
the exocervix near the vagina side; Both cells meet in an area called the
transformation zone, where the cells can change into pre-cancerous cells (American
Cancer Society, 2016). Squamous cell carcinomas and adenocarcinomas are the two
most common cervical cancers.
The HPV is contracted by having sexual intercourse. When infected with HPV it can
infect the cells of the cervix by producing E6 and E7 proteins that turn off tumor
suppressor genes that would normally control cell growth, but if turned off, cells can
now grow and can change into pre-cancerous cells (American Cancer Society, 2016).
HPV is not the only risk factor to cause cervical cancer. Other risk factors are smoking,
overweight, poor diet that’s low in fruits and vegetables, long-term use of oral
contraceptives, chlamydia, herpes simplex virus 2, multiple full-term pregnancies, and
immune deficiency (Kessler, 2017).
“HPV is the most common sexually transmitted infection worldwide and is the cause
of nearly all cases of cervical cancer”; Approximately 79 million men and women in
the US are infected with HPV and about 14 million will become newly infected each
year” (Kessler, 2017, p. 173). Most people are unaware they have HPV due to being
non-symptomatic. Once infected with the virus the body’s immune system can usually
clear it within 2 years. The two most common high-risk HPV strands that cause precancerous lesions are types 16 and 18; The most common low-risk HPV strands that
can cause genital warts are types 6 and 11 (Kessler, 2017).

•

The early stages of cervical cancer can be
asymptomatic (Johnson et al., 2019).

•

The “most common symptoms at presentation are
“irregular or heavy vaginal bleeding, particularly
following intercourse; Some women may present
with vaginal discharge that may be watery, mucoid,
or purulent and malodorous” (Johnson et al., 2019, p.
167).

•

Advanced stages of cervical cancer are “pelvic or
lower back pain; Bowel or bladder changes, such as
pressure-related complaints” (Johnson et al., 2019).

•

A pelvic exam should be performed with any
symptom complaints previous mentioned. There
could be a visible lesion or normal cervix during the
speculum exam, and the questionable lesion should
be biopsied, with a Pap smear performed (Johnson et
al., 2019).

It is important for healthcare providers to be familiar with methods of early prevention
and detection strategies for cervical cancer incidences. “Nearly 100% of cervical
cancer cases test positive for HPV” (Kessler, 2017). A way for both males and females
to decrease their chances of being infected with HPV is by practicing safe sex practices
whether by using a condom, limiting partners, or avoiding sex. Another solution is
getting the prophylactic HPV vaccination.
The US Food and Drug Administration (FDA) have made three vaccines available which
are Gardasil (4vHPV) in 2006, Cervarix (2vHPV) in 2009 and Gardasil 9 (9vHPV) in 2014
(Kessler, 2017). Each individual vaccine prevents an HPV type that is either cancerous
causing or warts.
•

•

The most recent vaccine Gardasil 9 prevents HPV types “6, 11, 16, 18, 31, 33, 45,
52, and 58” and is FDA approved for use in females ages 9 to 26, and males ages
9 to 15 up to three doses can be administered (Kessler, 2017, p. 176).
“The world health organization recommends that the primary target population
for the vaccination should be selected based on the age of imitation of sexual
activity and the feasibility of reaching young adolescent girls through schools,
health-care facilities, or community-based settings” (Swain & Parida, 2018, p.
38).

Cervical screening called the Papanicolaou cytology (Pap) tests is recommended
starting at age 21 in the U.S. to screen for abnormal cells in the cervix (Johnson et al.,
2019). Then at age 30, women should receive a pelvic exam annually, with a Pap tests
every 3 years, and HPV testing every 5 years till the age of 65 (Johnson et al., 2019).
Depending on the women’s risk factor for cervical cancer, the frequency of screenings
could change per healthcare providers recommendation.

(Cancer Institute NSW, 2019).

Implications for Nursing Care
Ways healthcare providers can encourage cervical cancer
screenings and prevention is by educating not only the adults
of the community, but the younger generation. The parents of
the younger generation need to be informed before their
children become sexually active and contract HPV by
unprotected intercourse. Educating as early as 11 years of age
is recommended (Kessler, 2017). The HPV vaccinations needs
to be encouraged not only for females but males who can also
be infected with HPV. There is a cost barrier for males to get
vaccinated for HPV, so healthcare providers can help find
clinics that offer reduced prices (Kessler, 2017). It is also
important to help women overcome barriers they may have
getting a Pap tests whether they are uninformed, anxiety, lack
of insurance coverage, or transportation (Kessler, 2017). The
Health Belief Model and the Transtheoretical Model can be
useful to healthcare providers to promote health behavior that
will help increase screenings and vaccinations (Kessler, 2017).
Knowledge alone does not promote behavior change, so
healthcare providers need to be convincing (Kessler, 2017).
Using the models mentioned can help better promote
behavioral change. Studies have shown that planned teaching
programs are effective in improving cervical cancer knowledge
to help women in early prevention and detection (Kusumlata
& Devi, 2019).

Conclusion

Image 2:
Gardasil 9 Vial
(Merck, 2015).

Cervical cancer incidences have declined over the
years in higher-income areas due to proper cervical
cancer screenings such as the Pap tests, known risk
factors such as HPV, and receiving the HPV
prophylactic vaccine. “It is the third most common
cause of death worldwide for those women who live
in low-resource or less developed countries”
(Kessler, 2017, p. 172). The proper education and
resources for the community on preventing cervical
cancer can help a community lower their risk.
Women need to be aware of any abnormal
symptoms to inform their healthcare provider and
get screened. Early detection is vital to preventing
the cancer from spreading.
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